NEWS

What we are up to:

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market H. PYLORI QUIK CHEK and H. PYLORI CHEK Tests

  BLACKSBURG, Va. – Aug. 21, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the H. PYLORI QUIK CHEK™ and the H. PYLORI CHEK™ tests. Both are designed to aid in the diagnosis of H. … Continue reading

August 21, 2018

PRESS RELEASE: TECHLAB® Products Identified As Meeting Updated Clinical Practice Guidelines For Clostridium Difficile Infection

  BLACKSBURG, Va. – Feb. 26, 2018 – TECHLAB®, Inc., today announced its products meet the updated Clinical Practice Guidelines for Clostridium difficile from The Infectious Disease Society of America (IDSA) and the Society of Healthcare Epidemiology of America (SHEA). The new recommendations recently published in the journal Clinical Infectious Diseases, emphasize the value of immunoassay toxin … Continue reading

February 26, 2018

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance to Market CAMPYLOBACTER QUIK CHEK and CAMPYLOBACTER CHEK Tests

  BLACKSBURG, Va. – January 23, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the CAMPYLOBACTER QUIK CHEK™ and the CAMPYLOBACTER CHEK™ tests. Both are intended to aid diagnosis of campylobacteriosis, one of the most common … Continue reading

January 23, 2018

PRESS RELEASE: Phoenix Lab to Offer GIARDIA VET CHEK From TECHLAB®

BLACKSBURG, Va. and MUKILTEO, Wash. – January 11, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the … Continue reading

January 11, 2018

PRESS RELEASE: Advanced Veterinary Laboratory to Offer GIARDIA VET CHEK From TECHLAB®

BLACKSBURG, Va. – January 3, 2018 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it will supply Advanced Veterinary Laboratory (AVL) with the GIARDIA VET CHEK™ test, the first USDA licensed Giardia microwell ELISA available for use in dogs and cats. The GIARDIA VET CHEK™ test offers … Continue reading

January 3, 2018

PRESS RELEASE: TECHLAB® Receives USDA Establishment License and Product License for GIARDIA VET CHEK™

BLACKSBURG, Va. – November 8, 2017 – TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received a USDA establishment license and product license for GIARDIA VET CHEK™. The test qualitatively detects Giardia cyst antigen in canine and feline fecal samples and is the first … Continue reading

November 17, 2017

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market TRI-COMBO PARASITE SCREEN™ To Aid Clinicians In The Diagnosis Of Giardiasis, Cryptosporidiosis, And Amebiasis

Read the full release here. BLACKSBURG, Va., July 13, 2017 /PRNewswire/ — TECHLAB®, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases, today announced that it received U.S. Food and Drug Administration (FDA) clearance for the TRI-COMBO PARASITE SCREEN™ test. The TRI-COMBO PARASITE SCREEN ™ test provides a complete analysis for Giardia, Cryptosporidium, and Entamoeba histolytica, the three most common intestinal protozoan … Continue reading

July 13, 2017

PRESS RELEASE: TECHLAB® Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK™ To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite

Read the full release here. BLACKSBURG, Va., June 13, 2017 /PRNewswire/ — TECHLAB®,® Inc., a leading developer and manufacturer of rapid, non-invasive diagnostic tests for gastrointestinal disease, today announced that it received U.S. Food and Drug Administration (FDA) clearance for E. HISTOLYTICA QUIK CHEK™ test.  E. HISTOLYTICA QUIK CHEK™ test is the only rapid diagnostic test that specifically detects pathogenic E. histolytica and does not … Continue reading

June 13, 2017